Idetrexed

N/A

Report date: 2026/03/11 20:02:12
NME

Base Information

Drug NameIdetrexed
Drug Alias NameBTG-945ONX-08016S-BGC-945CB-300945 (S)CT-900 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThymidylate synthase inhibitors
TargetsThymidylate synthase
Therapy Area/IndicationsSolid tumoursOvarian NeoplasmsCystadenocarcinoma, Serous
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBtg International Ltd
China Registration ClassN/A

Develop Information

Active CompaniesKeeps BioPharma IncAlgok Bio IncThe Institute Of Cancer Research, London
Inactive CompaniesOnyx Therapeutics Inc
Active IndicationsOvarian NeoplasmsCystadenocarcinoma, Serous
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A